SURGIFOAM Absorbable Gelatin Sponge
Ferrosan Meidcal Devices A/S · Decision date Sep 18, 2026
What did the FDA approve?
The supplied record lists PMA number P990004, supplement S080, for SURGIFOAM® Absorbable Gelatin Sponge, filed by Ferrosan Meidcal Devices A/S under product code LMF in the General and Plastic Surgery specialty. The supplement reason is "Change Design/Components/Specifications/Material" on the Normal 180 Day Track, and the decision is approval dated 2026-09-18. The stated purpose is "approval for thinning of inner tray foil," a packaging-component change.
The record does not establish that P990004 is the original PMA rather than a supplement identifier, so the supplement's relation to any earlier approval cannot be described beyond the fields shown. The notice covers the stated change only, not a new approval of the whole sponge system. The stated purpose is not independent proof of safety or clinical effectiveness, and no detail beyond the inner tray foil is supplied, including the extent of thinning.
FDA approval order statement
approval for thinning of inner tray foil
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 18, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P990004/S080
- Regulatory pathway
- PMA supplement
- Applicant
- Ferrosan Meidcal Devices A/S
- Product code
- LMF
- Decision code
- APPR
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Agent, absorbable hemostatic, collagen based.
- Applicant
- Ferrosan Meidcal Devices A/S
- Product code
- LMF
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P990004. Subsequent supplements may change the device or its indications.
FDA decision timeline
P990004 · Original PMA
SURGIFOAM ABSORBABLE GELATIN SPONGE, USP
P990004/S080 received
Application receipt date recorded by FDA.
P990004/S080 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P990004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P990004
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Ferrosan Meidcal Devices A/S | PMA approval | Sep 30, 1999 | FDA |
Explore the linked device profile
Other records with product code LMF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| C.R. Bard, Inc. | PMA supplement | Sep 29, 2026 | FDA | |
| Integra LifeSciences Corporation | PMA supplement | Sep 18, 2026 | FDA | |
| Integra LifeSciences Corporation | PMA supplement | Sep 18, 2026 | FDA | |
| Integra LifeSciences Corporation | PMA approval | Nov 8, 1985 | FDA | |
COLLASTATP810006 | Integra LifeSciences Corporation | PMA approval | Dec 10, 1981 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Ferrosan Meidcal Devices A/S
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Sydmarken 5, Soeborg, 08876
Sources and methodology
- Original FDA record: P990004/S080
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

